Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Lipoxen PLC 01 September 2011 Lipoxen plc ('Lipoxen' or the 'Company') Result of General Meeting Lipoxen (AIM: LPX.L), the bio-pharmaceutical company specialising in the development of high-value...
Lipoxen PLC 24 August 2011 Lipoxen plc ('Lipoxen' or the 'Company') Interim results for 6 months to 30 June 2011 Lipoxen (AIM: LPX.L), the bio-pharmaceutical company specialising in the...
Lipoxen PLC 04 August 2011 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO, WITHIN OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW...
Lipoxen PLC 04 July 2011 For immediate release 4 July 2011 LIPOXEN PLC Additional listing Lipoxen plc ("Lipoxen" or "the Company") announces that application has been made to AIM, a market of the...
Lipoxen PLC 28 June 2011 28 June 2011 Lipoxen plc Result of AGM Lipoxen (AIM: LPX.L), the bio-pharmaceutical company specialising in the development of high-value differentiated biologicals...
Lipoxen PLC 03 June 2011 Lipoxen plc ('Lipoxen' or the 'Company') Final results for the year ended 31 December 2010 & notice of AGM Lipoxen (AIM: LPX.L), a bio-pharmaceutical company...
Lipoxen PLC 04 May 2011 4 May 2011 Lipoxen plc ('Lipoxen' or the 'Company') US$100,000 grant win Lipoxen (AIM: LPX.L), a bio-pharmaceutical company specialising in the development of high-value...
Lipoxen PLC 05 April 2011 5 April 2011 Lipoxen plc ('Lipoxen' or the 'Company') IAVI collaboration update Lipoxen (AIM: LPX.L), a bio-pharmaceutical company specialising in the development of...
Lipoxen PLC 21 January 2011 Lipoxen plc ("Lipoxen" or the "Company") Director dealings The Company was informed on 20 January 2011 that FDS Pharma Ass and Related Parties disposed of 925,000...
Lipoxen PLC 16 December 2010 16th December 2010 Lipoxen plc ('Lipoxen' or the 'Company') Positive Phase II Clinical Data Lipoxen (AIM: LPX.L), a bio-pharmaceutical company specialising in the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
